Author:
Barnes Theresa C.,Moots Robert J.
Reference39 articles.
1. Li WQ, Dehnade F, Zafarullah M (2001) Oncostatin M-induced matrix metalloproteinase and tissue inhibitor of metalloproteinase-3 genes expression in chondrocytes requires janus kinase/STAT signalling pathway. J Immunol 166: 3491–3498
2. Cross A, Edwards SW, Bucknall R, Moots RJ (2004) Secretion of oncostatin M by neutrophils in rheumatoid arthritis. Arthritis Rheum 50: 1430–1436
3. Wahl AF, Wallace PM (2001) Oncostatin M in the anti-inflammatory response. Ann Rheum Dis 60: 75–80
4. Modur V, Feldhaus MJ, Weyrich AS, Jicha DL, Prescott SM, Zimmerman GA, McIntyre TM (1997) Oncostatin M is a proinflammatory mediator. In vivo effects correlate with endothelial cell expression of inflammatory cytokines and adhesion molecules. J Clin Invest 100: 158–168
5. Brown TJ, Lioubin MN, Marquardt H (1987) Purification and characterization of cytostatic lymphokines produced by activated human T lymphocytes: Synergistic antiproliferative activity of transforming growth factor β1, interferon γ and oncostatin M for human melanoma cells. J Immunol 139: 2977–2983
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献